These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15598554)

  • 1. QSAR analyses on ginkgolides and their analogues using CoMFA, CoMSIA, and HQSAR.
    Zhu W; Chen G; Hu L; Luo X; Gui C; Luo C; Puah CM; Chen K; Jiang H
    Bioorg Med Chem; 2005 Jan; 13(2):313-22. PubMed ID: 15598554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the pharmacophore of ginkgolides as glycine receptor antagonists.
    Jensen AA; Begum N; Vogensen SB; Knapp KM; Gundertofte K; Dzyuba SV; Ishii H; Nakanishi K; Kristiansen U; Strømgaard K
    J Med Chem; 2007 Apr; 50(7):1610-7. PubMed ID: 17352465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA, CoMSIA, and molecular hologram QSAR studies of novel neuronal nAChRs ligands-open ring analogues of 3-pyridyl ether.
    Zhang H; Li H; Liu C
    J Chem Inf Model; 2005; 45(2):440-8. PubMed ID: 15807510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
    Vogensen SB; Strømgaard K; Shindou H; Jaracz S; Suehiro M; Ishii S; Shimizu T; Nakanishi K
    J Med Chem; 2003 Feb; 46(4):601-8. PubMed ID: 12570381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity analysis of ginkgolide binding in the glycine receptor pore.
    Heads JA; Hawthorne RL; Lynagh T; Lynch JW
    J Neurochem; 2008 May; 105(4):1418-27. PubMed ID: 18221374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective agonism of human pregnane X receptor by individual ginkgolides.
    Lau AJ; Yang G; Yap CW; Chang TK
    Drug Metab Dispos; 2012 Jun; 40(6):1113-21. PubMed ID: 22393123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
    Pasha FA; Muddassar M; Neaz MM; Cho SJ
    J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
    Zhou YJ; Zhu LP; Tang Y; Ye DY
    Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF) receptor binding antagonists from Alpinia officinarum.
    Fan GJ; Kang YH; Han YN; Han BH
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6720-2. PubMed ID: 17964782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of CoMFA, advance CoMFA and CoMSIA models in pyrroloquinazolines as thrombin receptor antagonist.
    Dixit A; Kashaw SK; Gaur S; Saxena AK
    Bioorg Med Chem; 2004 Jul; 12(13):3591-8. PubMed ID: 15186843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
    He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
    J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors.
    Durdagi S; Mavromoustakos T; Papadopoulos MG
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6283-9. PubMed ID: 18951793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFalpha modulators.
    Avila CM; Romeiro NC; da Silva GM; Sant'Anna CM; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2006 Oct; 14(20):6874-85. PubMed ID: 16843662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation.
    Strømgaard K; Saito DR; Shindou H; Ishii S; Shimizu T; Nakanishi K
    J Med Chem; 2002 Aug; 45(18):4038-46. PubMed ID: 12190325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.
    Zou JW; Luo CC; Zhang HX; Liu HC; Jiang YJ; Yu QS
    J Mol Graph Model; 2007 Sep; 26(2):494-504. PubMed ID: 17418602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.